Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials-Reference-Cited by-同舟云学术

Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials

Published:2012-02 Issue:1 Volume:12 Page:30-39
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Strada Maria Rosa,Palumbo Raffaella,Bernardo Antonio,Riccardi Alberto,Teragni Cristina,Poggi Guido,Frascaroli Mara,Amatu Alessio,Montagna Benedetta,Sottotetti Federico,Tagliaferri Barbara,Bernardo Giovanni

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference54 articles.

1. The curability of breast cancer and the treatment of advanced disease;Guarneri;Eur J Nucl Med Mol Imaging,2004

2. Optimizing the treatment of metastatic breast cancer;Gralow;Breast Cancer Res Treat,2005

3. Goals of treatment for patients with metastatic breast cancer;Smith;Semin Oncol,2006

4. Strategies of medical treatment for metastatic breast cancer: what is expected in 2001 and beyond;Estava;Oncologist,2001

5. Systemic treatment of breast cancer;Seidman;Oncology (Williston Park),2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-arm, Prospective Study;Cancer Research and Treatment;2023-10-12

2. Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis;Future Science OA;2021-12

3. Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM);Clinical and Translational Oncology;2018-10-16

4. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer;Clinical Breast Cancer;2017-04

5. Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies;Clinical Breast Cancer;2016-10